Ancrod for coronary angioplasty.
Anticoagulation in the form of intravenous heparin is used after coronary angioplasty to prevent thrombosis. Ancrod, a rapid-acting defibrinogenating agent, has been used in various clinical settings that require anticoagulation. We present the use of ancrod after percutaneous transluminal coronary angioplasty in a patients with heparin-induced thrombopathia.
Pothoulakis
A J
AJ
Department of Internal Medicine, Medical College of Ohio, Toledo 43699, USA.
Neerukonda
S K
SK
Ansel
G
G
Jantz
R D
RD
D000368:Aged; D000721:Ancrod / Q000627:therapeutic use*; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006493:Heparin / Q000009:adverse effects; D006801:Humans
D000925:Anticoagulants; D006493:Heparin; D000721:Ancrod